UniProt ID | AGM1_HUMAN | |
---|---|---|
UniProt AC | O95394 | |
Protein Name | Phosphoacetylglucosamine mutase {ECO:0000305} | |
Gene Name | PGM3 {ECO:0000312|HGNC:HGNC:8907} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 542 | |
Subcellular Localization | ||
Protein Description | Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation.. | |
Protein Sequence | MDLGAITKYSALHAKPNGLILQYGTAGFRTKAEHLDHVMFRMGLLAVLRSKQTKSTIGVMVTASHNPEEDNGVKLVDPLGEMLAPSWEEHATCLANAEEQDMQRVLIDISEKEAVNLQQDAFVVIGRDTRPSSEKLSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYCRNTGGRYGKATIEGYYQKLSKAFVELTKQASCSGDEYRSLKVDCANGIGALKLREMEHYFSQGLSVQLFNDGSKGKLNHLCGADFVKSHQKPPQGMEIKSNERCCSFDGDADRIVYYYHDADGHFHLIDGDKIATLISSFLKELLVEIGESLNIGVVQTAYANGSSTRYLEEVMKVPVYCTKTGVKHLHHKAQEFDIGVYFEANGHGTALFSTAVEMKIKQSAEQLEDKKRKAAKMLENIIDLFNQAAGDAISDMLVIEAILALKGLTVQQWDALYTDLPNRQLKVQVADRRVISTTDAERQAVTPPGLQEAINDLVKKYKLSRAFVRPSGTEDVVRVYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLGAITK -------CCCCHHCC | 9.65 | 22223895 | |
8 | Ubiquitination | MDLGAITKYSALHAK CCCCHHCCHHHHHCC | 30.97 | 21890473 | |
42 | Sulfoxidation | LDHVMFRMGLLAVLR HHHHHHHHHHHHHHH | 2.79 | 28465586 | |
50 | Phosphorylation | GLLAVLRSKQTKSTI HHHHHHHCCCCCCEE | 25.59 | 28985074 | |
55 | Phosphorylation | LRSKQTKSTIGVMVT HHCCCCCCEEEEEEE | 28.75 | 23927012 | |
56 | Phosphorylation | RSKQTKSTIGVMVTA HCCCCCCEEEEEEEC | 24.25 | 23927012 | |
60 | Oxidation | TKSTIGVMVTASHNP CCCEEEEEEECCCCC | 1.54 | 17322306 | |
62 | Phosphorylation | STIGVMVTASHNPEE CEEEEEEECCCCCCC | 12.35 | 22167270 | |
64 | Phosphorylation | IGVMVTASHNPEEDN EEEEEECCCCCCCCC | 17.90 | 29255136 | |
86 | Phosphorylation | LGEMLAPSWEEHATC CHHCCCCCHHHHHHH | 41.32 | 30206219 | |
92 | Phosphorylation | PSWEEHATCLANAEE CCHHHHHHHHHCCCH | 15.23 | 30206219 | |
110 | Phosphorylation | QRVLIDISEKEAVNL HHEEEECCHHHHCCC | 38.58 | 29759185 | |
177 | Ubiquitination | NTGGRYGKATIEGYY CCCCCCCEEEHHHHH | 33.16 | - | |
177 | Malonylation | NTGGRYGKATIEGYY CCCCCCCEEEHHHHH | 33.16 | 26320211 | |
186 | Ubiquitination | TIEGYYQKLSKAFVE EHHHHHHHHHHHHHH | 38.31 | - | |
189 | Ubiquitination | GYYQKLSKAFVELTK HHHHHHHHHHHHHHH | 57.17 | 1890473 | |
196 | Ubiquitination | KAFVELTKQASCSGD HHHHHHHHHCCCCCC | 57.39 | - | |
199 | Phosphorylation | VELTKQASCSGDEYR HHHHHHCCCCCCCCC | 13.30 | 30624053 | |
205 (in isoform 1) | Ubiquitination | - | 15.39 | 21906983 | |
209 | Acetylation | GDEYRSLKVDCANGI CCCCCCCEEECCCCC | 36.96 | 26051181 | |
209 | Ubiquitination | GDEYRSLKVDCANGI CCCCCCCEEECCCCC | 36.96 | - | |
217 (in isoform 1) | Ubiquitination | - | 26.67 | 21906983 | |
220 | Ubiquitination | ANGIGALKLREMEHY CCCCCHHHHHHHHHH | 44.99 | - | |
244 | Acetylation | FNDGSKGKLNHLCGA ECCCCCCCHHHHCCC | 50.26 | 25953088 | |
244 | Ubiquitination | FNDGSKGKLNHLCGA ECCCCCCCHHHHCCC | 50.26 | - | |
255 | Ubiquitination | LCGADFVKSHQKPPQ HCCCCHHHHCCCCCC | 42.06 | - | |
259 | Ubiquitination | DFVKSHQKPPQGMEI CHHHHCCCCCCCCEE | 53.92 | - | |
264 | Sulfoxidation | HQKPPQGMEIKSNER CCCCCCCCEECCCCC | 3.97 | 30846556 | |
267 | Ubiquitination | PPQGMEIKSNERCCS CCCCCEECCCCCEEC | 33.64 | - | |
307 | Phosphorylation | KIATLISSFLKELLV HHHHHHHHHHHHHHH | 27.83 | 24719451 | |
319 | Phosphorylation | LLVEIGESLNIGVVQ HHHHHHHHCCEEEEE | 22.85 | 24719451 | |
327 | Phosphorylation | LNIGVVQTAYANGSS CCEEEEEEEECCCCC | 15.27 | 23828894 | |
343 | Ubiquitination | RYLEEVMKVPVYCTK HHHHHHHCCCEEECC | 48.87 | - | |
347 | Phosphorylation | EVMKVPVYCTKTGVK HHHCCCEEECCCCCC | 6.58 | 24719451 | |
349 | Phosphorylation | MKVPVYCTKTGVKHL HCCCEEECCCCCCCC | 17.60 | - | |
350 | Ubiquitination | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | - | |
350 | Malonylation | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | 26320211 | |
350 | Acetylation | KVPVYCTKTGVKHLH CCCEEECCCCCCCCC | 39.46 | 25953088 | |
354 | Ubiquitination | YCTKTGVKHLHHKAQ EECCCCCCCCCCCCC | 41.62 | - | |
376 | Phosphorylation | FEANGHGTALFSTAV EEECCCCEEEHHHHH | 17.95 | - | |
388 | Ubiquitination | TAVEMKIKQSAEQLE HHHHHHHHHHHHHHH | 32.45 | 21906983 | |
397 | Ubiquitination | SAEQLEDKKRKAAKM HHHHHHHHHHHHHHH | 45.14 | 2190698 | |
398 | Acetylation | AEQLEDKKRKAAKML HHHHHHHHHHHHHHH | 72.03 | 7481271 | |
416 (in isoform 1) | Ubiquitination | - | 13.46 | 21906983 | |
425 (in isoform 1) | Ubiquitination | - | 2.74 | 21906983 | |
453 | Ubiquitination | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | - | |
453 | Acetylation | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | 25953088 | |
453 | Malonylation | DLPNRQLKVQVADRR CCCCCEEEEEEECCE | 23.45 | 26320211 | |
463 | Phosphorylation | VADRRVISTTDAERQ EECCEEECCCHHHHH | 23.54 | 20068231 | |
464 | Phosphorylation | ADRRVISTTDAERQA ECCEEECCCHHHHHC | 19.99 | 20068231 | |
465 | Phosphorylation | DRRVISTTDAERQAV CCEEECCCHHHHHCC | 26.82 | 20068231 | |
498 | Phosphorylation | SRAFVRPSGTEDVVR CCEECCCCCCCCEEE | 48.02 | 27050516 | |
500 | Phosphorylation | AFVRPSGTEDVVRVY EECCCCCCCCEEEEE | 33.09 | 23186163 | |
526 | Phosphorylation | LAHEVSLAVFQLAGG HHHHHHHHHHHHCCC | 7.80 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AGM1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGM1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGM1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
ENOPH_HUMAN | ENOPH1 | physical | 26344197 | |
HDHD1_HUMAN | HDHD1 | physical | 26344197 | |
LACB2_HUMAN | LACTB2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615816 | Immunodeficiency 23 (IMD23) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. |